The Role of Hydro Facials in Your Skincare Routine
July 29, 2026
Understanding When To Visit Urgent Care
July 29, 2026
Prostate cancer is the second most common malignant cancer among men worldwide, following lung cancer. Early detection supports timely treatment, and screening provides one method for identifying the disease before symptoms appear. When cancer is found early, it is possible to manage and effectively treat the disease, which makes detection a key part of cancer care.
Defining Prostate Cancer
Prostate cancer begins when cells in the prostate divide and multiply uncontrollably. The prostate is a small, walnut-shaped gland that produces seminal fluid, and most cancers develop slowly and remain in the pelvic region. Some cancers grow more aggressively, and they spread to other parts of the body when the disease advances.
Symptoms include difficulty urinating, decreased force in the urine stream, blood in the urine or semen, bone pain and erectile dysfunction. Significant unexplained weight loss may also occur as cancer progresses, and symptoms can prompt further evaluation when they appear. Early detection does not depend only on symptoms, because some cancers develop slowly and remain localized.
Identifying Key Risk Factors
Age is a risk factor for prostate cancer. Men 50 and older face greater risk, and a family history of the disease also increases risk. Obesity is another risk factor, while race may play a role as well, although the reasons for racial differences remain unclear. Genetic factors also contribute to risk. BRCA2 mutations and Lynch syndrome are documented contributors, and a family history involving a father or brother raises risk. Risk factors vary among individuals, so screening discussions account for personal and family history when providers evaluate potential risk.
Examining Screening Tools
A digital rectal examination allows a provider to assess the prostate’s shape, size and location. A prostate-specific antigen test measures the amount of PSA in the bloodstream; levels outside the normal range may indicate infection, inflammation or cancer. These tests provide information about the prostate, while additional evaluation may follow when the results do not provide enough information. Imaging provides another diagnostic option. Ultrasound or MRI supplies additional detail; a tissue biopsy may also be used. A biopsy examines prostate tissue, while imaging provides information that supports further evaluation when initial measures are insufficient.
Reviewing Treatment Options
Treatment options include cryo-ablation therapy, radiation therapy, hormone therapy, chemotherapy and radical prostatectomy. Greenlight laser surgery is another available treatment; targeted drug therapy uses special drugs to target specific abnormalities in cancer cells. Treatment approaches differ, so providers select options according to the cancer and the circumstances of the individual case.
Early detection supports treatment when prostate cancer remains manageable and treatable. The disease can develop slowly, but some cancers grow more aggressively and spread beyond the pelvic region. Detecting the disease before it advances provides information about its status; that information helps guide the evaluation of treatment options.
Seek Prostate Cancer Screening
Early detection is part of cancer care. Screening and diagnostic tests provide information about the prostate; additional evaluation may follow when initial results require clarification. When prostate cancer is detected early, it is possible to manage and effectively treat the disease, while treatment options address different stages and characteristics of the condition.
